SEC Comment Letter for HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494) (HBIO) — Aug 16, 2023

HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)
Date: Aug. 16, 2023 · CIK: 0001123494 · Accession: 0000000000-23-008957

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-33957

Date

August 16, 2023

Author

James Green

Form

UPLOAD

Company

HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)

Letter

United States securities and exchange commission logo August 16, 2023 James Green Chief Executive Officer Harvard Bioscience, Inc. 84 October Hill Road Holliston, MA 01746-1371 Re:Harvard Bioscience, Inc. Definitive Proxy Statement on Schedule 14A Filed April 5, 2023 File No. 001-33957 Dear James Green: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text

United States securities and exchange commission logo
August 16, 2023
James Green
Chief Executive Officer
Harvard Bioscience, Inc.
84 October Hill Road
Holliston, MA 01746-1371
Re:Harvard Bioscience, Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 5, 2023
File No. 001-33957
Dear James Green:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program

SecProbe.io